European Antibiotic Awareness day: More needs to be done!
19.11.12
To tackle this important issue the Innovative Medicines Initiative (IMI) launched in May the €223.7 million New Drugs for Bad Bugs programme which brings together leading academics and five major pharmaceutical companies with the aim of speeding up the delivery of much-needed new antibiotics to patients. IMI’s programme is part of the European Commission’s Action Plan against the rising threats from Antimicrobial Resistance, which was launched in November last year. New projects under this programme will be launched in December 2012.
In order to overcome these hurdles this type of collaboration is critical. The rational use of antibiotics is extremely important, and it has to be complemented with research and development of new molecules to address current and future health challenges posed by resistant bacteria. It is only by bringing the public and private sector together that we will find the answers to these extremely important issues. IMI is perfectly suited for such open innovation, said Richard Bergström.
Read more:
New Drugs for Bad Bugs programme
Forthcoming IMI projects under New Drugs for Bad Bugs
Media contact:
Nicholas Elles
Communications Manager
EFPIA
Rue du Trone, 108
1050 Brussels
TEL: 0032.2.626.24.79
Email : communications@efpia.eu